Eur J Prev Cardiol. 2023 Sep 1:zwad285. doi: 10.1093/eurjpc/zwad285. Online ahead of print.

ABSTRACT

AIMS: To investigate the associations between passive tobacco smoke exposure and daily smoking with a comprehensive metabolic profile, measured repeatedly from childhood to adulthood.

METHODS: Study cohort was derived from the Special Turku Coronary Risk Factor Intervention Project(STRIP). Smoking status was obtained by questionnaire, while serum cotinine concentrations were measured using gas chromatography. Metabolic measures were quantified by nuclear magnetic resonance metabolomics at 9(n = 539), 11(n = 536), 13(n = 525), 15(n = 488), 17(n = 455), and 19(n = 409) years. Association of passive tobacco smoke exposure with metabolic profile compared participants who reported less-than-weekly smoking and had serum cotinine concentration <1 ng/mL(no exposure) to those whose cotinine concentration was ≥10 ng/mL(passive tobacco smoke exposure). Associations of daily smoking with metabolic profile in adolescence were analysed by comparing participants reporting daily smoking to those reporting no tobacco use and having serum cotinine concentrations <1 ng/mL.

RESULTS: Passive tobacco smoke exposure was directly associated with the serum ratio of monounsaturated fatty acids to total fatty acids (β=0.34SD, [0.17-0.51], p < 0.0001) and inversely associated with the serum ratios of polyunsaturated fatty acids. Exposure to passive tobacco smoke was directly associated with VLDL particle size (β=0.28SD, [0.12-0.45], p = 0.001), and inversely associated with HDL particle size (β=-0.21SD, [-0.34-(-0.07)], p = 0.003). Daily smokers exhibited a similar metabolic profile to those exposed to passive tobacco smoke. These results persisted after adjusting for body mass index, STRIP study group allocation, dietary target score, pubertal status, and parental socio-economic status.

CONCLUSIONS: Both passive and active tobacco smoke exposure during childhood and adolescence are detrimentally associated with circulating metabolic measures indicative of increased cardiometabolic risk.

PMID:37655930 | DOI:10.1093/eurjpc/zwad285